Ibukunoluwa Naiyeju
Ph.D. Candidate
Biological and Biomedical Engineering
Co-supervisor: Dr. Stephanie Lehoux
Email: ibukunoluwa.naiyeju@mail.mcgill.ca
Education Background:
Master of Science in Advanced Drug Delivery, University of Strathclyde, Glasgow, Scotland (2020)
Bachelor of Pharmacy, University of Ibadan, Ibadan, Nigeria (2016)
Favourite Lab Equipment:
Centrifuge
“Embrace the possibilities.”
Research Projects and Interests:
Atherosclerosis is a chronic disease where fatty plaques grow inside arteries and block the blood flow to the organs these arteries supply. As a result of this blockage, unmanaged atherosclerosis can progress to heart disease and other life-threatening events such as heart attacks and strokes. One of the key processes which sustains the progression of atherosclerosis is inflammation. However, there is currently a limitation to our knowledge about this inflammatory process due to a scarcity of 3D demo plaque models. In my project, I am working to address this knowledge gap by developing a novel three-dimensional (3D) demo model to understudy inflammation inside the fatty plaque. Through the insights we gain, we hope to contribute to the advancement of knowledge about atherosclerosis management in the field of biomedical engineering.
-
McGill University:
BBME GREAT Travel Award (2023)
Faculty of Medicine & Health Sciences Internal Studentship (2023)
BBME Differential Fee Waiver (2022)
Biological and Biomedical Engineering PhD Recruitment Award (2021)
University of Strathclyde:
Master of Science with Distinction (2020)
Faculty of Science Postgraduate Elite Scholarship (2019)
University of Ibadan:
Distinction Awards: Pharmaceutics & Industrial Pharmacy, Pharmacology & Therapeutics, Social & Administrative Pharmacy, Pharmaceutical Microbiology, and Pharmaceutical Chemistry (2016)
Agbami/Chevron Nigeria Scholarship Award for outstanding medical undergraduates in training (2012-2016)
-
Peer-Reviewed Abstracts:
Naiyeju I., Lehoux S. and Tabrizian M. (2023). The 33rd Annual Conference of the European Society for Biomaterials (ESB 2023), Davos Congress Center, Davos, Switzerland. (Page 250). https://www.ariabstracts.org/abstracts/2023/Collection3/Posters%20ESB2023.pdf
Book Chapters:
Naiyeju, I. and Bimbo, L. (2021). Biocompatibility of porous silicon. Hélder A. Santos. Porous Silicon for Biomedical Applications. 2nd Ed. Chapter 5. Woodhead Publishing (Elsevier).
Working Papers:
Naiyeju, I. (2020). Simulated interaction between Janus Kinase 3 (JAK3) and peficitinib (a kinase inhibitor) using Discovery Studio Visualizer®.
Naiyeju, I. (2019). Artificial Intelligence and the Future of Medical Diagnosis.
Alkhaldi, B., Paspali, E., and Naiyeju, I. (2019). Is Oral Ciclosporin Really Absorbed Effectively from the Gastrointestinal Tract?
-
Conferences:
Naiyeju I., Lehoux S. and Tabrizian M. (2023). Co-culture spheroids as in vitro models to replicate the microenvironment of the vulnerable atherosclerotic plaque. The 7th Biological & Biomedical Engineering Symposium, McGill University, Montreal, Canada. (poster presentation)
Naiyeju I., Lehoux S. and Tabrizian M. (2023). Development of co-culture spheroids as potential models for atherosclerotic disease modelling. The 33rd Annual Conference of the European Society for Biomaterials (ESB 2023), Davos Congress Center, Davos, Switzerland. (poster presentation)
-
Pharmaceutical Sciences
Science communication
STEM/Education advocacy
-
Creative Writer & Editor, Camwood Carats©
Graduate Student Representative (School of Biomedical Sciences), Faculty of Medicine Council
McGill Bicentennial Volunteer